Taxanes Hypersensitivity is not a risk factor for severe reactions to SARS-Cov-2 Vaccines

Conclusions. In our cohort Patients with history of reaction to taxanes were not at higher risk to develop anaphylaxis to SARS-CoV-2 vaccines. However, a common non-IgE mediated mechanism behind those HSRs cannot be completely excluded. This can only account for mild and harmless symptoms in case of SARS-CoV-2 vaccines. Antihistamine premedication and longer observation after the vaccination are still prudent in these patients.PMID:36047485 | DOI:10.23822/EurAnnACI.1764-1489.265

Source: European Annals of Allergy and Clinical Immunology - September 1, 2022 Category: Allergy & Immunology Authors: G Cortellini A Raiteri B Biagioni S Liberati D Lippolis G Cortellini F Piscaglia Source Type: research